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background: In the absence of anti-proliferative drugs (APD), the specific contribution of polymer coatings to vascular reactions remains poorly 
defined. Objective: To examine the comparative healing response after implantation of stents coated with permanent or biodegradable polymer and 
uncoated stents in a porcine model of coronary artery stenting.
Methods: Juvenile pigs were randomly allocated to implantation of stents coated with permanent polymer (PP, methacrylate-based, n=10), 
biodegradable polymer (BP, poly-lactic acid-based, n=10) or bare metal control stents (n=10), in the absence of APD. At 28 days, animals were 
sacrificed and specimens prepared for histopathologic assessment.
results: A total of 30 stents were implanted in 28 pigs. At 28 days endothelialization was complete in all treatment groups. In terms of vessel wall 
inflammation, PP stents showed significantly increased inflammatory scores compared with BP coated (p=0.03) and uncoated stents (p=0.02). There 
was also significantly greater neointimal growth with PP coated stents compared with uncoated stents (p=0.02).
conclusion: In the absence of anti-proliferative drugs, stents coated with methacrylate-based PP, but not with poly-lactic acid-based BP, provoked 
significant vessel wall inflammatory reactions and increased neointimal growth compared with uncoated stents. The use of biodegradable polymer 
coatings may be the preferable approach to facilitate drug elution with a minimum of vessel wall toxicity.
 
